Edwin DeJesus

机构：Orlando Immunology Center

发表论文 215 篇 · 总被引 19482 次 · h-index 75

代表论文

• Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (2022 · New England Journal of Medicine · 被引 311)
• Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial (2022 · Nature Medicine · 被引 144)
• Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials (2023 · EClinicalMedicine · 被引 88)
• Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial (2023 · The Lancet HIV · 被引 71)
• Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial (2024 · Nature Medicine · 被引 60)
• Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study (2024 · The Lancet HIV · 被引 47)